EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
1-Year Return
14.19%
This Quarter Return
+15.13%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$519M
AUM Growth
-$40.8M
(-7.3%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-19.95%
Top 10 Holdings %
Top 10 Hldgs %
72.99%
Holding
27
New
1
Increased
4
Reduced
8
Closed
2
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$14.8M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$13.2M |
| 3 |
DexCom
DXCM
|
$11.8M |
| 4 |
Illumina
ILMN
|
$8.95M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$2.07M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$40.6M |
| 2 |
IQVIA
IQV
|
$25.8M |
| 3 |
UnitedHealth
UNH
|
$21.2M |
| 4 |
Guardant Health
GH
|
$18.1M |
| 5 |
Transmedics
TMDX
|
$18M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Guardant Health
GH
$7.44B
| – | – |
-626,909
| Closed | -$18.1M |
|
|
27
IQVIA
IQV
$31B
| – | – |
-121,895
| Closed | -$25.8M |
|